Pediatric
Oncology Subcommittee of the Oncologic Drugs Advisory Committee
October 9, 2003
Bibliography
AM
Session
- Frost,
B-M. Pharmacokinetics of
Doxorubicin in Children With Acute Lymphoblastic
Leukemia: Multi-Institutional Collaborative Study. Med
Pediatr Oncol. 2002; 38:329-337.
- Groninger,
E, et al. Pharmacokinetics of
Vincristine Monotherapy in Childhood Acute Lymphoblastic Leukemia. Ped
Rsch. 2002;2(1):113-118.
- Hempel, G, et.al. Peak
plasma concentrations of doxorubicin in children with acute lymphoblastic
leukemia or non-Hodgkin lymphoma.
Canc Chemother and Pharm.
2001
- Nath, CE.
Population pharmacokinetics
of amphotericin B in children with malignant diseases. J Clin Pharmacol. 2001; 52:671-680.
PM
Session
- Pawar,
S. and Kumar, A. Issues in the Formulation of Drugs for
Oral Use in Children – Role of Excipients. Pediatr Drugs. 2002; 4(6):371-379.
- Nahata,
MC. Pediatric Drug Formulations:
Challenges and Potential Solutions.
Annals of Pharmacother. Feb
1999; 33:247-249.
- Kovarik,
JM, et.al. Clinical Development of an Everolimus Pediatric Formulation:
Relative Bioavailability, Food Effect, and Steady-State Pharmacokinetics. J Clin Pharmacol. 2003;43:141-147.